Amended Statement of Beneficial Ownership (sc 13d/a)
05 Gennaio 2016 - 5:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
(Amendment No. 1)
Under The Securities Exchange Act of 1934
BioAdaptives Inc.
F/K/A
APEX 8 Inc.
(Name of Issuer)
Common Stock, $0.0001 Par Value Per Share
(Title of Class of Securities)
Applied For
(CUSIP Number)
Richard Chiang
460 Brannan Street, Suite 78064
San Francisco, CA 94107
Telephone: (415) 713 6957
Email: rchiang8@gmail.com
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 20, 2013
(Date Of Event Which Requires Filing Of This
Statement)
If the filing person has previously filed a
statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because
of Rule 13d-1(e), (f) or (g), check the following box o.
SCHEDULE 13D
(1) |
NAMES OF REPORTING PERSONS. S.S. OR I.R.S. IDENTIFICATION
NOS. OF ABOVE PERSONS (ENTITIES ONLY):
Richard Chiang |
(2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
|
(a) |
o |
|
|
(b) |
o |
|
|
|
|
|
|
(4) |
SOURCE OF FUNDS (SEE INSTRUCTIONS) |
N/A
(5) |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) o |
(6) |
CITIZENSHIP OR PLACE OF ORGANIZATION |
United States
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING PERSON
WITH
|
(7) SOLE VOTING POWER |
0 |
(8) SHARED
VOTING POWER |
0 |
(9) SOLE DISPOSITIVE
POWER |
0 |
(10) SHARED
DISPOSITIVE POWER |
0 |
(11) |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
0
(12) |
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o |
(13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
0
(14) |
TYPE OF REPORTING PERSON |
IN
ITEM 1. SECURITY AND ISSUER.
The security upon which this report is based is the common stock,
par value $0.0001 per share, of BioAdaptives Inc, F/K/A APEX 8 Inc., a Delaware corporation, with its principal place of business
located at 1003 S Cimarron Rd, Las Vegas, NV 89145.
ITEM 2. IDENTITY AND BACKGROUND.
(a) Name: Richard Chiang
(b) Address: 460 Brannan Street, Suite 78064
San Francisco, CA 94107
(c) Business consultant and private investor
(d) None.
(e) None.
(f) Citizenship: USA
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
The Reporting Person, Richard
Chiang, sold 10,000,000 shares of the Issuer in a private transaction to Ferris Holding Inc.
and received the sum of $40,000 in cash. After the sale, Mr. Chiang owns no shares of the common stock of the Issuer.
ITEM 4. PURPOSE OF TRANSACTION.
The purpose of the transaction was for a change in control of the
Issuer, based on a private sale of 10,000,000 shares of common stock of the Issuer by Reporting Person Richard Chiang to Ferris
Holdings Inc. The transaction closed on June 20, 2013.
On June 20, 2013, the Registrant accepted the
resignations of Richard Chiang as the Registrant’s President, Chief Executive Officer, Chief Financial Officer, Secretary
and Chairman of the Board of Directors. These resignations are in connection with the consummation of the Share Purchase Agreement
with Ferris Holding Inc.,and was not the result of any disagreement with Registrant on any matter relating to Registrant's operations,
policies or practices. Effective as of the same date, to fill the vacancies created by Richard Chiang’s resignations, the
Registrant elected and appointed Barry Epling as Chairman of the Board of Directors of the Registrant and Gerald Epling as President,
Chief Executive Officer, Secretary, and Chief Financial Officer.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Richard Chiang beneficially owns no shares
of the Issuer's Common Stock.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS
OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.
Other than as described in this Schedule 13D/A,
the Reporting Person has no contracts, arrangements, understandings or relationships with any other person with respect to any
securities of the Issuer.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None. The Registrant filed a Current Report on
Form 8-K August 6, 2013 as Exhibit 10.1.
SIGNATURE
After reasonable inquiry and to the best of
my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Signature:
/s/ Richard Chiang
Richard Chiang
Grafico Azioni Bioadaptives (PK) (USOTC:BDPT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Bioadaptives (PK) (USOTC:BDPT)
Storico
Da Giu 2023 a Giu 2024